Trial Profile
Phase IIIb, Randomized, Triple-blinded and Crossover Study to Evaluate the Effect of Magnesium Pantoprazole 20mg Bid Versus Magnesium Pantoprazole 40mg qd on Intragastric Acid Inhibition Assessed by pHmetry, in Healthy Volunteers
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2013
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Duodenal ulcer; Erosive oesophagitis; Gastritis; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacodynamics
- Sponsors Takeda
- 31 Aug 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 30 Dec 2011 New trial record